Small Biotechs Are Pulling Public Offerings, IPOs Amid ‘Current Market Conditions’
RNA biotech TransCode Therapeutics Inc (NASDAQ:RNAZ) withdrew its S-1 filing with the SEC that it made in late November. TransCode said…
Reported Late Tuesday, Intrinsic Medicine And Phoenix Biotech Acquisition Corp. Mutually Agree To Terminate Business Combination Agreement
Intrinsic Medicine, Inc. (Intrinsic), a therapeutics company leveraging human milk biology to transform Gut-Brain Axis (GBA) and inflammatory disorders, and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)